Early warning symptoms of hypoglycaemia include: Trembling or shakiness Sweating (often profuse) Anxiety or irritability Palpitations or rapid heartbeat Hunger Tingling lips or tongue Pallor (pale appearance) If hypoglycaemia progresses without treatment, more severe symptoms may develop, including confusion, difficulty concentrating, blurred vision, weakness, drowsiness, and in extreme cases, loss of consciousness or seizures
Skipping Doses: Both medications are weekly injections, so missing a dose can throw things off track
Initiation rates for ADM GLP-1 RA increased slightly in March 2024, relative to December 2023 (+1.72%)
Commercial launch prices: projected $1,000$1,500/month before discounts Compounded versions: $200$600/month, varies by dose and supplier Starting or sub-clinical doses are less than $100 per month, sometimes below $50
GLP-1 receptor agonists slow gastric emptying, potentially leaving food in the stomach beyond standard fasting periods
Key details Compounded semaglutide and tirzepatide in injection and microdose injection formats are available